Histiocytic sarcoma: A case report and review of the literature;Sarcoma histiocítico: Caso clínico y revisión de la literatura

Anales de Medicina Interna

Volumn 22, Issue 4, 2005, Pages 185-187

  Khosravi Shahi, Parham ^a   Del Castillo Rueda, A ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

CD68; Histiocytic sarcoma; Lysozyme; Pancytopenia; True histiocytic lymphoma

Indexed keywords

AGED; ANOREXIA; BONE MARROW EXAMINATION; CASE REPORT; CLINICAL EXAMINATION; DISEASE COURSE; FATIGUE; FEMALE; FEVER; HEPATOSPLENOMEGALY; HISTIOCYTE; HISTIOCYTIC SARCOMA; HISTIOCYTOSIS; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; INTESTINE OBSTRUCTION; LYMPHADENOPATHY; PANCYTOPENIA; RASH; REVIEW; SARCOMA; SPLENOMEGALY; SYMPTOM; SYSTEMIC DISEASE; WEIGHT REDUCTION;

AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HISTIOCYTOSIS, MALIGNANT; HUMANS; IMMUNOPHENOTYPING; SARCOMA;

EID: 19544393922     PISSN: 02127199     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Elghetany MT. True histiocytic lymphoma: is it an entity? Leukemia. 1997; 11: 762-4.
2. Copie-Bergman C, Wotherspoon AC, Norton AJ, Diss TC, Isaacson PG. True histiocytic lymphoma: a morphologic, immunohistochemical, and molecular genetic study of 13 cases. Am J Surg Pathol 1998; 22: 1386-92.
3. Kimura H, Nasu K, Sakai C, Shiga Y, Miyamoto E, Shintaku M, et al. Histiocytic sarcoma of the spleen associated with hypoalbuminemia, hypo gamma-globulinemia and thrombocytopenia as a possibly unique clinical entity-report of three cases. Leuk Lymphoma 1998; 31: 217-24.
4. Osborne BM, Mackay B. True histiocytic lymphoma with multiple skin nodules. Ultrastruct Pathol 1994; 18: 241-6.
5. Sun W, Nordberg ML, Fowler MR. Histiocytic sarcoma involving the central nervous system: clinical, immunohistochemical, and molecular genetic studies of a case with review of the literature. Am J Surg Pathol 2003; 27: 258-65.
6. Pileri S, Mazza P, Rivano MT et al. Malignant histiocytosis (true histiocytic lymphoma) clinicopathological study of 25 cases. Histopathology 1985; 9: 905-20.
7. Pileri SA, Grogan TM, Harris NL, Banks P, Campo E, Chan JK, et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 2002; 41: 1-29.
8. Krenacs L, Tiszalviez L, Krenacs T, Boumsell L. Immunohistochemical detection of CD1a antigen in formalin-fixed and paraffin-embedded tissue sections with monoclonal antibody 010. J Pathol 1993; 100: 285-92.
9. Ralfkiaer E, Delsol G, O'Connor NTJ, Brandtzaeg P, Brousset P, Vejlsgaard GI, et al. Malignant lymphomas of true histiocytic origin. A clinical, histological, immunophenotypic and genotypic study. J Pathol 1990; 160: 9-17.
10. Rajkumar SV, Dispenzieri A, Fonseca R, Lacy MQ, Geyer S, Lust JA et al. Thalidomide for previously untreated indolent or smoldering multiple myeloma. Leukemia 2001; 15: 1274-1276.
11. Baidas S, Tfayli A, Bhargava P. Thalidomide: an old drug with new clinical applications. Cancer Invest 2002; 20: 835-848.
12. Dalle JH, Leblond P, Decouvelaere A, Yakoub-Agha I, Preudhomme C, Nelken B, et al. Efficacy of thalidomide in a child with histiocytic sarcoma following allogeneic bone marrow transplantation for T-ALL. Leukemia 2003; 17: 2056-7.